Changes in rat myocardium associated with modulation of ischemic tolerance by diazoxide

General Physiology and Biophysics

Volumn 26, Issue 2, 2007, Pages 75-85

  Simoncikova P ^a   Ravingerova T ^a   Andelova E ^a   Tribulova N ^a   Barančík, Miroslav ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Cell signaling; Diazoxide; Heart; Regulatory proteins

Indexed keywords

CASPASE 3; DIAZOXIDE; GELATIN; GELATINASE A; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN ANTIBODY; PROTEIN BAX; PROTEIN BCL 2; REGULATOR PROTEIN;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CYTOSOL; ELECTRON MICROSCOPY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HEART CONTRACTION; HEART MITOCHONDRION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; ISOLATED HEART; MALE; MITOCHONDRIAL RESPIRATION; NONHUMAN; PROTEIN INDUCTION; PROTEIN SYNTHESIS REGULATION; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; DIAZOXIDE; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MATRIX METALLOPROTEINASE 2; MICROSCOPY, ELECTRON; MITOCHONDRIA, HEART; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, WISTAR;

RATTUS;

EID: 34548730847     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Biatt N. B., Glick G. D. (2001): Signaling pathways and effector mechanisms pre-programmed cell death. Bioorg. Med. Chem. 9, 1371-1384
2. Bradford M. (1976): A rapid and sensitive method for the quantitation of microgram quanties of protein utilizing the principle of protein-dye-binding. Anal. Biochem. 72, 248-254
3. Burbridge M. F., Coge F., Galizzi J. P., Boutin J. A., West D. C., Tucker G. C. (2002): The role of the matrix metalloproteinases during in vitro vessel formation, Angiogenesis 5, 215-226
4. Cohen M. V., Baines C. P., Downey J. M. (2000): Ischemic preconditioning: from adenosine receptor to KATP channel. Annu. Rev. Physiol. 62, 79-109
5. Datta S. R., Dudek H., Tao X., Masters S., Fu H., Gotoh Y., Greenberg M. E. (1997): Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91, 231-241
6. Donnini S., Morbidelli L., Taraboletti G., Ziche M. (2004): ERK1-2 and p38 MAPK regulate MMP/TIMP balance and function in response to thrombospondin-1 fragments in the microvascular endothelium, Life Sci. 74, 2975-2985
7. Forbes R. A., Steenbergen C., Murphy E. (2001): Diazoxide-induced cardioprotection requires signaling through a redox-sensitive mechanism. Circ. Res. 88, 802-809
8. Fryer R. M., Hsu A. K., Gross G. J. (2001): Mitochondrial K(ATP) channel opening is important during index ischemia and following myocardial reperfusion in ischemic preconditioned rat hearts. J. Mol. Cell. Cardiol. 33, 831-834
9. + channel in cardiac function and cardioprotection. Biochim. Biophys. Acta 1606, 1-21
10. Giricz Z., Lalu M. M., Csonka C., Bencsik P., Schulz R., Ferdinandy, P. (2006): Hyperlipidemia attenuates the infarct size-limiting effect of ischemic preconditioning: role of matrix metalloproteinase-2 inhibition. J. Pharmacol. Exp. Ther. 316, 154-161
11. Kolář F., Oštádal B. (2004): Molecular mechanisms of cardiac protection by adaptation to chronic hypoxia. Physiol. Res. 53, S3-13
12. Kloner R. A., Jennings R. B. (2001): Consequences of brief ischemia: stunning, preconditioning, and their clinical implications. Circulation 104, 2981-2989
13. Kukreja R. C., Salloum F., Das A., Ockaili R., Yin C., Bremer Y. A., Fisher P. W., Wittkamp M., Hawkins J., Chou E., Kukreja A. K., Wang X., Marwaha V. R., Xi L. (2005): Pharmacological preconditioning with sildenafil: Basic mechanisms and clinical implications. Vasc. Pharmacol. 42, 219-232
14. Lalu M. M., Csonka C., Giricz Z., Csont T., Schulz R., Ferdinandy P. (2002): Preconditioning decreases ischemia/reperfusion-induced release and activation of matrix metalloproteinase-2. Biochem. Biophys. Res. Commun. 296, 937-941
15. Ma X. L., Kumar S., Gao F., Louden C. S., Lopez B. L., Christopher T. A., Wang C., Lee J. C., Feuerstein G. Z., Yue T. L. (1999): Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Circulation 99, 1685-1691
16. 2+ overload during simulated ischemia and reperfusion: possible mechanism of cardioprotection. Circ. Res. 89, 891-898
17. Murry C. E., Jennings R. B., Reimer K. A. (1986): Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74, 1124-1136
18. Oldenburg O., Qin Q., Krieg T., Yang X. M., Philipp S., Critz S. D., Cohen M. V., Downey J. M. (2004): Bradykinin induces mitochondrial ROS generation via NO, cGMP, PKG, and mitoKATP channel opening and leads to cardioprotection. Am. J. Physiol., Heart. Circ. Physiol. 286, H468-476
19. Ozcan C., Bienengraeber M., Dzeja P. P., Terzic A. (2002): Potassium channel openers protect cardiac mitochondria by attenuating oxidant stress at reoxygenation. Am. J. Physiol., Heart Circ. Physiol. 282, H531-539
20. Robinson M. J., Cobb M. H. (1997): Mitogen-activated protein kinase pathways. Curr. Opin. Cell. Biol. 9, 180-186
21. Samavati L., Monick M. M., Sanlioglu S., Buettner G. R., Oberley L. W., Hunninghake G. W. (2002): Mitochondrial K(ATP) channel openers activate the ERK kinase by an oxidant-dependent mechanism. Am. J. Physiol., Cell. Physiol. 283, C273-281
22. Scheid M. P., Schubert K. M., Duronio V. (1999): Regulation of bad phosphorylation and association with Bcl-x(L) by the MAPK/Erk kinase. J. Biol. Chem. 274, 31108-31113
23. Schonbeck U., Mach F., Sukhova G. K., Murphy C., Bonnefoy J. Y., Fabunmi R. P., Libby P. (1997): Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes. Circ. Res. 81, 448-454
24. Siwik D. A., Colucci W. S. (2004): Regulation of matrix metalloproteinases by cytokines and reactive oxygen/nitrogen species in the myocardium. Heart Fail. Rev. 9, 43-51
25. Strnisková M., Barančík M., Ravingerová T. (2002): Mitogen-activated protein kinases and their role in regulation of cellular processes. Gen. Physiol. Biophys. 21, 231-255
26. Strnisková M., Barančík M., Neckář J., Ravingerová T. (2003): Mitogen-activated protein kinases in the acute diabetic myocardium. Mol. Cell. Biochem. 249, 59-65
27. Strohm C., Barančík M., Bruhl M. L., Kilian S. A., Schaper W. (2000): Inhibition of the ER-kinase cascade by PD98059 and UO 126 counteracts ischemic preconditioning in pig myocardium. J. Cardiovasc. Pharmacol. 36, 218-229
28. Strohm C., Barančík M., Bruhl M. L., Strnisková M., Ullmann C., Zimmermann R., Schaper W. (2002): Transcription inhibitor actinomycin-D abolishes the cardioprotective effect of ischemic preconditioning. Cardiovas. Res. 55, 602-618
29. ATP channel elicits late preconditioning against myocardial infarction via protein kinase C signaling pathway. Circ. Res. 85, 1146-1153
30. Tsukamoto O., Asanuma H., Kim J., Minamino T., Takashima S., Ogai A., Hirata A., Fujita M., Shinozaki Y., Mori H., Tomoike H., Hori M., Kitakaze M. (2005): A role of opening of mitochondrial ATP-sensitive potassium channels in the infarct size-limiting effect of ischemic preconditioning via activation of protein kinase C in the canine heart. Biochem. Biophys. Res. Commun. 338, 1460-1466
31. Wang W., Sawicki G., Schulz R. (2002): Peroxynitrite-induced myocardial injury is mediated through matrix metalloproteinase-2. Cardiovasc. Res. 53, 165-174
32. Yue T. L., Wang C., Gu J. L., Ma X. L., Kumar S., Lee J. C., Feuerstein G. Z., Thomas H., Maleeff B., Ohlstein E. H. (2000): Inhibition of extracellular signal-regulated kinase enhances ischemia/ reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart. Circ. Res. 86. 692-699
33. Yue Y., Qin Q., Cohen M. V., Downey J. M., Critz S. D. (2002): The relative order of mK(ATP) channels, free radicals and p38 MAPK in preconditinng's protective pathway in rat heart. Cardiovasc. Res. 55, 681-689
34. Zhang D., Bar-Eli M., Meloche S., Brodt R (2004): Dual regulation of MMP-2 expression by the type 1 insulin-like growth factor receptor: the phosphatidylinositol 3-kinase/Akt and Raf/ERK pathways transmit opposing signals. J. Biol. Chem. 279, 19683-19690